Skip to main content

Table 1 Patient Characteristics by Tumor Grade

From: Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysis

 

Grade 1 (n = 28)

Grade 2 (n = 52)

Grade 3 (n = 79)

Total (n = 159)

No. (%)

No. (%)

No. (%)

No. (%)

Age (years)

 Median (Range)

63.5 (42–92)

62 (32–87)

62 (31–89)

62 (31–92)

  < 50

2 (7.1)

8 (15.4)

9 (11.4)

19 (11.9)

 50–64

13 (46.4)

22 (42.3)

36 (45.6)

71 (44.7)

 65–74

8 (28.6)

14 (26.9)

24 (30.4)

46 (28.9)

  ≥ 75

5 (17.9)

8 (15.4)

10 (12.7)

23 (14.5)

Race

 White

24 (85.7)

45 (86.5)

63 (79.7)

132 (83)

 Black

1 (3.6)

4 (7.7)

12 (15.2)

17 (10.7)

 Other

3 (10.7)

3 (5.8)

4 (5.1)

10 (6.3)

FIGO Stage

 I

11 (39.3)

8 (15.4)

21 (26.6)

40 (25.2)

 II

0 (0.0)

8 (15.4)

7 (8.9)

15 (9.4)

 III

15 (53.6)

28 (53.8)

38 (48.1)

81 (50.9)

 IV

2 (7.1)

6 (11.5)

13 (16.5)

21 (13.2)

 Unknown

0 (0.0)

2 (3.8)

0 (0.0)

2 (1.3)